Literature DB >> 2743704

Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women.

H Friedman1, D J Greenblatt, J M Scavone, E S Burstein, H R Ochs, J S Harmatz, R I Shader.   

Abstract

A single oral dose of doxylamine succinate 25 mg was administered to 21 young (20 to 43 years) and 22 elderly (60 to 87 years) volunteers. Multiple plasma doxylamine concentrations were determined during a 30-hour period after each dose. Elderly and young women did not differ significantly in peak plasma doxylamine concentration (Cmax) [116 vs 103 micrograms/L], time to Cmax (tmax) [2.4 vs 2.4 h], elimination half-life (12.2 vs 10.1 h), volume of distribution (179 vs 176 L) or clearance (191 vs 218 ml/min). Cmax (107 vs 108 micrograms/L) and tmax (2.1 vs 1.6 h) also did not differ between elderly and young men. However, elderly men had reduced doxylamine clearance (174 vs 240 ml/min, p less than 0.02; 2.5 vs 3.2 ml/min/kg, p less than 0.07) and prolonged half-life (15.5 vs 10.2 h, p less than 0.05). The reduced doxylamine clearance and prolonged half-life in elderly men, but not in elderly women, is similar to results for many other drugs which are transformed by oxidation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2743704     DOI: 10.2165/00003088-198916050-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  23 in total

1.  Reduced single-dose clearance of clobazam in elderly men predicts increased multiple-dose accumulation.

Authors:  D J Greenblatt; M Divoll; S K Puri; I Ho; M A Zinny; R I Shader
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

2.  Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

Review 3.  Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).

Authors:  D M Paton; D R Webster
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

4.  Doxylamine metabolism in rat and monkey.

Authors:  D A Ganes; K W Hindmarsh; K K Midha
Journal:  Xenobiotica       Date:  1986-09       Impact factor: 1.908

5.  Over-the-counter medication: the drug interactions we overlook.

Authors:  P P Lamy
Journal:  J Am Geriatr Soc       Date:  1982-11       Impact factor: 5.562

6.  Trazodone kinetics: effect of age, gender, and obesity.

Authors:  D J Greenblatt; H Friedman; E S Burstein; J M Scavone; G T Blyden; H R Ochs; L G Miller; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1987-08       Impact factor: 6.875

7.  Formation of artifactual metabolites of doxylamine following acid hydrolysis.

Authors:  C L Holder; W A Korfmacher; L G Rushing; H C Thompson; W Slikker; A B Gosnell
Journal:  J Chromatogr       Date:  1987-08-07

8.  Effect of age, gender, and obesity on midazolam kinetics.

Authors:  D J Greenblatt; D R Abernethy; A Locniskar; J S Harmatz; R A Limjuco; R I Shader
Journal:  Anesthesiology       Date:  1984-07       Impact factor: 7.892

Review 9.  Pharmacokinetics of drugs in obesity.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

10.  Metabolism of 14C-labeled doxylamine succinate (Bendectin) in the rhesus monkey (Macaca mulatta).

Authors:  W Slikker; C L Holder; G W Lipe; W A Korfmacher; H C Thompson; J R Bailey
Journal:  J Anal Toxicol       Date:  1986 May-Jun       Impact factor: 3.367

View more
  7 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety.

Authors:  Larry Culpepper; Mark A Wingertzahn
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-31

Review 3.  Switching drug availability from prescription only to over-the-counter status. Are elderly patients at increased risk?

Authors:  S I Benrimoj; J H Langford; M G Bowden; E J Triggs
Journal:  Drugs Aging       Date:  1995-10       Impact factor: 3.923

4.  Food effects on the pharmacokinetics of doxylamine hydrogen succinate 25 mg film-coated tablets: a single-dose, randomized, two-period crossover study in healthy volunteers.

Authors:  Sebastián Videla; Mounia Lahjou; Pascal Guibord; Zhengguo Xu; Carles Tolrà; Gregorio Encina; Eric Sicard; Artur Sans
Journal:  Drugs R D       Date:  2012-12-01

5.  Bioavailability of Triprolidine as a Single Agent or in Combination With Pseudoephedrine: A Randomized, Open-Label Crossover Study in Healthy Volunteers.

Authors:  Salvatore Febbraro; Tim Shea; Ana Santos Cravo
Journal:  Clin Pharmacol Drug Dev       Date:  2020-03-04

Review 6.  The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.

Authors:  Yong Ling; Zhi-You Hao; Dong Liang; Chun-Lei Zhang; Yan-Fei Liu; Yan Wang
Journal:  Drug Des Devel Ther       Date:  2021-10-13       Impact factor: 4.162

7.  Pharmacokinetic dose proportionality between two strengths (12.5 mg and 25 mg) of doxylamine hydrogen succinate film-coated tablets in fasting state: a single-dose, randomized, two-period crossover study in healthy volunteers.

Authors:  Sebastián Videla; Jesús Cebrecos; Mounia Lahjou; France Wagner; Pascal Guibord; Zhengguo Xu; Anna Cabot; Mercedes Encabo; Gregorio Encina; Eric Sicard; Artur Sans
Journal:  Drugs R D       Date:  2013-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.